Lhasa Limited shared knowledge shared progress

Publication list per product

Vitic NexusVitic Nexus Publications

The following links provide access to relevant Vitic Nexus publications for the last 2 years. If you would like to view older publications, or to refine your search criteria further please search the library.

TitlePublishedTypeProducts
Carcinogenicity Adverse Outcome PathwaysJanuary 2020pdf fileDerek NexusVitic Nexus
Achieving Innovation Through Collaborative ProgressNovember 2019pdf fileDerek NexusVitic NexusIntermediates
Aromatic Amines 2019.1.0 Release NotesOctober 2019pdf fileVitic Nexus
Intermediates Database 2019.1.0 Release NotesJune 2019pdf fileIntermediatesVitic Nexus
Excipients Database 2019.1.0 Release NotesJune 2019pdf fileExcipientsVitic Nexus
Use of In Silico Tools for Toxicity Prediction Within ICH M7June 2019pdf fileDerek NexusSarah NexusVitic Nexus
The Honest Broker's ChallengeJune 2019pdf fileVitic NexusExcipientsIntermediates
Q3D Regulatory Case StudyJune 2019pdf fileVitic Nexus
ICHQ3D Implementation: Use of published data driven risk assessmentsJune 2019pdf fileVitic Nexus
RDC53: Challenges on impurities qualificationJune 2019pdf fileDerek NexusSarah NexusVitic NexusZeneth
Introduction to Lhasa - Applying ICH M7 - What makes an expertMay 2019pdf fileDerek NexusMirabilisSarah NexusMeteor NexusVitic Nexus
Modelling Simple Toxicity Endpoints: Alerts, (Q)SARs and BeyondMay 2019Derek NexusMeteor NexusSarah NexusVitic Nexus
A Suggested ICH M7 Framework Using Lhasa Limited ProductsMay 2019pdf fileZenethVitic NexusMirabilisSarah NexusDerek Nexus
A Case Study in Predicting hERG Activity.April 2019Derek NexusSarah NexusMirabilisMeteor NexusVitic NexusZenethSetaria
How low can you go? An analysis of lowest effective dose in the Ames test.April 2019Vitic Nexus
ICH M7 Perception: Unifying Knowledge from Predictions to PurgingMarch 2019pdf fileMirabilisSetariaDerek NexusSarah NexusVitic Nexus
A defined approach for predicting skin sensitisation hazard and potency based on the guided integration of in silico, in chemico and in vitro data using exclusion criteriaJanuary 2019Derek NexusVitic Nexus
Welcome and Introduction to ICH M7 - ICH M7 India RoadshowsNovember 2018pdf fileDerek NexusSarah NexusVitic Nexus
Derek Nexus, Sarah Nexus and Vitic: How they fit into ICH M7 - ICH M7 India RoadshowsNovember 2018pdf fileDerek NexusSarah NexusVitic Nexus
An adverse outcome pathway framework to support developmental and reproductive toxicity risk assessmentsNovember 2018pdf fileDerek NexusSarah NexusVitic Nexus
Important considerations for the validation of QSAR models for in vitro mutagenicityNovember 2018Derek NexusSarah NexusVitic Nexus
Vitic 3.1 Installation GuideOctober 2018pdf fileVitic Nexus
Integrating Knowledge Of Carcinogenicity Adverse Outcome Pathways (AOPs) With Experimental DataOctober 2018pdf fileDerek NexusVitic Nexus
Development Of A Network Of Adverse Outcome Pathways (AOPs) For CarcinogenicitySeptember 2018pdf fileVitic NexusDerek NexusSarah Nexus
Quantifying Degree of Aromaticity from Structural FeaturesSeptember 2018pdf fileVitic Nexus
How low can you go? An analysis of lowest effective dose in the Ames test.September 2018pdf fileVitic Nexus
Vitic 3.1 Release NotesSeptember 2018pdf fileVitic Nexus
Aromatic Amines 2018.1.0 Release NotesJuly 2018pdf fileVitic Nexus
Vitic - A Faster, More Efficient Searching ExperienceJuly 2018Vitic Nexus
Elemental Impurities Data Sharing InitiativeJuly 2018pdf fileVitic Nexus
Vitic 2018.1.0 Release NotesJune 2018pdf fileVitic Nexus
Improving Toxicity Predictions through knowledge and data sharingJune 2018pdf fileDerek NexusExcipientsIntermediatesiPiEVitic Nexus
Intermediates Database 2018.1.0 Release NotesJune 2018pdf fileIntermediatesVitic Nexus
Excipients Database 2018.1.0 Release NotesJune 2018pdf fileVitic NexusExcipients
A Defined Approach to Skin Sensitisation: Integrating Derek Nexus with In Chemico/In Vitro Assays - A SummaryApril 2018Derek NexusVitic Nexus
Making reliable negative predictions of human skin sensitisation using an in silico fragmentation approachMarch 2018Derek NexusVitic Nexus
49th ICGM Product Manager UpdateMarch 2018pdf fileDerek NexusMeteor NexusMirabilisSarah NexusSetariaVitic NexusZeneth
Vitic: Lhasa’s Toxicity Information Management SystemMarch 2018pdf fileVitic Nexus
Vitic BrochureMarch 2018pdf fileVitic Nexus
ICH M7 BrochureMarch 2018pdf fileDerek NexusSarah NexusVitic NexusZeneth
Vitic PDE 2018.1.0 Release NotesJanuary 2018pdf fileVitic Nexus
Skin Sensitisation BrochureJanuary 2018pdf fileDerek NexusVitic Nexus
Progress on Lhasa's Toxicity Information Management SystemNovember 2017pdf fileVitic Nexus
An Overview of Lhasa Limited Collaborative Data Sharing InitiativesOctober 2017pdf fileDerek NexusETOXExcipientsIntermediatesVitic Nexus
Improving Chemical Space Coverage of an In Silico Prediction System by Targeted Inclusion of Fragments Absent from the Training SetSeptember 2017pdf fileIntermediatesSarah NexusVitic Nexus
Acceptable Intake and Permitted Daily Exposure Data Sharing Project for Pharmaceutical ImpuritiesSeptember 2017Vitic Nexus
Aromatic Amines 2017.1.0 Release NotesJuly 2017pdf fileVitic Nexus
Vitic PDE 2017.1.0 Release NotesJuly 2017pdf fileVitic Nexus
Japanese ICH M7 ExamplesMay 2017pdf fileDerek NexusSarah NexusVitic Nexus
Vitic 2017.1.0 Release NotesMay 2017pdf fileIntermediatesExcipientsVitic Nexus
46th ICGM Product Manager UpdateMarch 2017pdf fileDerek NexusMeteor NexusMirabilisSarah NexusSetariaVitic NexusZeneth
Expert review of the mutagenicity of carbamates - using (Q)SAR predictions for ICH M7 classificationMarch 2017pdf fileDerek NexusSarah NexusVitic Nexus
In Silico Strategies to Assess Potentially Mutagenic Impurities Under ICH M7March 2017pdf fileDerek NexusSarah NexusMirabilisVitic Nexus
SEND to Vitic 1.0 Installation Guide.pdfNovember 2016pdf fileETOXVitic Nexus
Advantages in Utilizing an Integrated In Silico Solution for ICH M7 Expert ReviewNovember 2016pdf fileDerek NexusMeteor NexusSarah NexusVitic NexusZeneth
SEND to Vitic 1.0 ReleaseNotes.pdfNovember 2016pdf fileETOXVitic Nexus
Vitic Database Installation Guide 2016November 2016pdf fileVitic Nexus
Mutagenicity Prediction Using In Silico Methods: Gigabyte-Sized Petri DishesJune 2016pdf fileDerek NexusZenethVitic NexusSarah NexusMirabilisMeteor Nexus
Aromatic Amines 2016.1.0 Release Notes.pdfJune 2016pdf fileVitic Nexus
Is preclinical data sharing the new norm?May 2016Derek NexusETOXExcipientsIntermediatesMeteor NexusVitic Nexus
Summation of Toxicity Data in ViticMarch 2016Vitic Nexus
43rd ICGM Product UpdateMarch 2016pdf fileSarah NexusVitic NexusDerek NexusIntermediatesExcipientsMeteor NexusZenethSetaria
Implementation of ICH M7 Recommended (Q)SAR AnalysesMarch 2016pdf fileDerek NexusSarah NexusVitic NexusZeneth
Advantages in Utilizing an Integrated In Silico Solution for ICH M7 Expert ReviewMarch 2016pdf fileDerek NexusMirabilisSarah NexusVitic NexusZeneth
Vitic 2016.1.0 Release NotesFebruary 2016pdf fileVitic NexusExcipientsIntermediates
Mutagenic Impurities: Precompetitive/Competitive Collaborative and Data Sharing InitiativesMay 2015Derek NexusExcipientsIntermediatesMirabilisSarah NexusVitic NexusZeneth
Vitic Nexus 2.6 Release NotesFebruary 2015pdf fileVitic Nexus
Vitic Nexus 2.6 Installation GuideFebruary 2015pdf fileVitic Nexus
Value of shared preclinical safety studies - the eTOX databaseDecember 2014ETOXVitic Nexus

© 2020 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.